Comera Life Sciences Holdings Inc (CMRA) Financials

$0.02

$-0.01 (-23.45%)

As on 03-Oct-2024 16:00EDT

Market cap

$1 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	1.00	0.63	0.32	0.44	--	--
Cost of Revenue	0.26	0.21	0.16	0.10	--	--
Gross Profit	0.74	0.42	0.16	0.34	--	--
Operating Expenses	9.88	12.39	5.69	2.47	--	--
Operating Profit (EBIT)	-9.15	-11.97	-5.54	-2.13	--	--
Other Income	--	--	--	--	--	--
Profit before Tax	-9.01	-18.00	-5.45	-2.13	--	--
Provision for Tax	75.23	6.03	-0.16	-0.12	--	--
Profit after Tax (Net Income)	-84.25	-24.04	-5.29	-2.13	--	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-6.04	-18.38	-5.45	-2.13	--	--

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	-4.22	-6.25	-14.69	0.15	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	4.36	4.92	21.06	0.16	--	--
Current Liabilities	2.93	5.06	1.05	0.23	--	--
Total Liabilities	6.00	3.73	7.42	0.55	--	--

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	0.44	0.66	0.64	0.24	--	--
Current Assets	2.63	3.06	6.78	0.31	--	--
Total Assets	6.00	3.73	7.42	0.55	--	--
Total Debt*	0.17	0.78	0.32	0.16	--	--
Net Current Assets	-0.30	-2.00	5.74	0.08	--	--

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-9.77	-3.76	-1.80	--	--
Cash Flow from Investing Activities	--	-0.03	-0.14	-0.01	--	--
Cash from Financing Activities	--	5.24	10.28	1.55	--	--
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-4.53	-2.30	-0.28	--	--	--
Cash EPS ($)	--	-2.29	-0.27	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.93	-0.20	--	--	--
Free Cash Flow per Share ($)	--	-0.94	-0.20	--	--	--

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	242.38	75.32	--	--	--
ROE (%)	--	229.66	72.81	--	--	--
ROA (%)	-1,172.49	-431.37	-132.88	--	--	--
EBIT Margin (%)	-917.18	-2,121.13	-1,781.84	-480.34	--	--
Net Margin (%)	-8,421.91	-3,796.89	-1,654.37	-479.88	--	--
Cash Profit Margin (%)	-0.08	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	81.79	0.98	-0.28	--	--	--
EBIT Growth (%)	17.27	-135.64	-167.87	--	--	--
Net Profit Growth (%)	-264.00	-354.31	-148.94	--	--	--
EPS Growth (%)	-101.53	-7.30	--	--	--	--
Book Value Growth (%)	14.64	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-0.53	-36.54	--	--	--
Price / Book Value	--	-2.06	-13.17	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.28	-0.99	-33.36	--	--	--
Close Price ($)	0.29	1.23	10.13	10.30	--	--
High Price ($)	2.17	15.30	10.50	10.47	--	--
Low Price ($)	0.26	1.11	9.75	9.86	--	--
Market Cap ($ Cr)	0.68	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	-0.12	-0.02	1.06	--	--
Short term debt to equity ratio	-0.04	-0.10	-0.01	0.69	--	--
Current Ratio	0.90	0.61	6.49	1.33	--	--
Quick Ratio	0.93	0.11	6.49	1.24	--	--
Interest Coverage	-356.82	-658.57	-67.97	--	--	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	10.00	5.42	69.27	26.02	--	--
Asset Turnover	0.14	0.11	0.08	--	--	--
Receivable days	--	73.81	192.33	95.05	--	--
Inventory Days	--	2,179.87	27.13	76.69	--	--
Payable days	--	1,627.74	583.64	341.49	--	--
Cash Conversion Cycle	--	625.94	-364.18	-169.74	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.